Q301--Decipher Contract Base 4

Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Notices whose amount is a placeholder such as $999,999,999 are not added in. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.

• Jun 11, 2026PROPATH SERVICES, LLC$4.0MQ301--NEW - NTX Combined Reference Lab Testing (Anatomic, Surgical, Genetic) IDIQNo listed company matched (Materiality N/A)
• Apr 27, 2026LABORATORY CORPORATION$17.0MQ301--STX Specialized Reference Lab TestingNo listed company matched (Materiality N/A)
• Mar 29, 2026LABORATORY CORPORATION$815KQ301--South Texas VA Specialized Reference Lab Testing 3 Month OrderNo listed company matched (Materiality N/A)
• Mar 3, 2026QUEST DIAGNOSTICS INCORPORATED$12.4MQ301--Specialized Reference Lab Services BPA South Texas Veterans Healthcare SystemMateriality: 0.11% of $DGX revenue (Low)How big this award is next to the company's revenue over the last 12 months: Low under 1%, Medium 1-5%, High 5% or more. Award amount divided by revenue from the company's SEC filings. Here: $12.4M award ÷ $11.8B revenue, 12 months to Sep 30, 2026 (SEC 10-Q). SEC
• Feb 27, 2026QUEST DIAGNOSTICS INCORPORATED$5.5MQ301--New - NTX Reference TestingMateriality: 0.05% of $DGX revenue (Low)How big this award is next to the company's revenue over the last 12 months: Low under 1%, Medium 1-5%, High 5% or more. Award amount divided by revenue from the company's SEC filings. Here: $5.5M award ÷ $11.8B revenue, 12 months to Sep 30, 2026 (SEC 10-Q). SEC
• Feb 27, 2026QUEST DIAGNOSTICS INCORPORATED$12.8MQ301--Reference Laboratory Testing Services BPA El Paso Veterans Healthcare SystemMateriality: 0.11% of $DGX revenue (Low)How big this award is next to the company's revenue over the last 12 months: Low under 1%, Medium 1-5%, High 5% or more. Award amount divided by revenue from the company's SEC filings. Here: $12.8M award ÷ $11.8B revenue, 12 months to Sep 30, 2026 (SEC 10-Q). SEC
• Feb 26, 2026AMBRY GENETICS CORPORATION$62KQ301--Specialized Genetic Testing ServicesNo listed company matched (Materiality N/A)
• Jan 20, 2026QUEST DIAGNOSTICS INCORPORATED$4.6MQ301--Reference Laboratory Services Central Texas Veterans Healthcare SystemMateriality: 0.04% of $DGX revenue (Low)How big this award is next to the company's revenue over the last 12 months: Low under 1%, Medium 1-5%, High 5% or more. Award amount divided by revenue from the company's SEC filings. Here: $4.6M award ÷ $11.8B revenue, 12 months to Sep 30, 2026 (SEC 10-Q). SEC
• Jan 7, 2026QUEST DIAGNOSTICS INCORPORATED$2.0MWest Texas VA Reference Lab TestingMateriality: 0.02% of $DGX revenue (Low)How big this award is next to the company's revenue over the last 12 months: Low under 1%, Medium 1-5%, High 5% or more. Award amount divided by revenue from the company's SEC filings. Here: $2.0M award ÷ $11.8B revenue, 12 months to Sep 30, 2026 (SEC 10-Q). SEC
• Jan 7, 2026QUEST DIAGNOSTICS INCORPORATED$2.0MQ301--West Texas VA Reference Lab TestingMateriality: 0.02% of $DGX revenue (Low)How big this award is next to the company's revenue over the last 12 months: Low under 1%, Medium 1-5%, High 5% or more. Award amount divided by revenue from the company's SEC filings. Here: $2.0M award ÷ $11.8B revenue, 12 months to Sep 30, 2026 (SEC 10-Q). SEC

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.